“…These may be due to the impaired respiratory mechanics, increased airway resistance and impaired gas exchange [ 25 , 28 , 54 ], as well as obesity-related comorbidities [ 63 ], which appear to be directly related to the onset of complications and severe course of COVID-19. In particular, OSAS [ 38 ], metabolic syndrome, hypertension, Non-Alcoholic Fatty Liver Disease (NAFLD) and diabetes or insulin resistance have all shown to affect COVID-19 outcome negatively [ 55 , 56 , 57 , 58 ]. Finally, it should not be overlooked that obesity is associated with low chronic inflammation within a state of immunological dysfunction that can lead to increased risk of allergies [ 64 ] or ineffective response against infections [ 35 ] and vaccines [ 65 ].…”